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Abstract
Background. In the management of chronic diseases, treatment approaches have changed in recent decades. Not 
only are clinical outcomes assessed but also the patients’ perception of their quality of life has become an important 
aspect.
Objectives. The aim of our study was to compare the health-related quality of life (HRQoL) of children with cystic 
fibrosis (CF) to the HRQoL of asthmatic patients, to assess the level of agreement between parent proxy-report and 
child self-report and to measure the relationship between spirometry and HRQoL.
Material and Methods. 172 children (mean age: 11.61 ± 2.56 years) and their parents completed the questionnaire. 
The Hungarian version of the Pediatric Quality of Life InventoryTM 4.0 (PedsQLTM 4.0) Generic Core Scale was 
used to assess HRQoL. Lung function was assessed via spirometry.
Results. Significantly lower PedsQLTM scores were measured for CF patients on the psychosocial health (p < 0.05), 
emotional functioning (p < 0.005) and school functioning (p < 0.01) subscales and the total scale (p < 0.05) from 
the children’s self-report. The level of child-parent agreement was fair and moderate in both patient populations 
[intra-class correlation coefficient range (ICC) asthma = 0.29–0.37; ICCCF = 0.39–0.59, p < 0.001]. The relation-
ship between forced expiratory volume in 1 second (FEV1) and the physical health subscale (r = 0.49, p < 0.01) 
was moderate in young (8–12 years) children and also teenagers (13–18 years), with CF (r = 0.58, p < 0.05) from 
self-report. We found weak, non-significant correlations between FEV1 and PedsQLTM subscales in children with 
asthma (8–12 years) (r = –0.01–0.18, ns.).
Conclusions. Children suffering from CF perceive their HRQoL as poorer than children with asthma. In asthmatic 
patients, it is not sufficient to evaluate clinical outcomes (FEV1); subjective HRQoL should be also estimated in the 
course of patient care (Adv Clin Exp Med 2015, 24, 3, 487–495).
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Chronic diseases account for the majority of 
total disease burden both in adult and pediatric 
populations due to their mortality and morbidi-
ty, hence measuring quality of life is of major im-
portance [1–4]. Traditionally, clinical outcomes 
such as spirometry are used to assess the prog-
ress of respiratory diseases and the effectiveness 
of treatment but these fail to evaluate the impact 
the disease has on children’s everyday physical, so-
cial, emotional and school functioning as well as 
their perception of their chronic illness. In the last 
decade, gaining better overall disease control has 
become more important than measuring the pa-
tients’ health status according to only objective pa-
rameters [5–7]. 
Nevertheless, disease prevalence, mortality and 
impact on health related quality of life (HRQoL) are 
different; consequently, their contribution to over-
all health burden is not similar [1–4]. In our cross-
sectional, multi-center study, two chronic respirato-
ry conditions were chosen, cystic fibrosis (CF) and 
bronchial asthma, each of which has a considerable 
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effect on the patient’s HRQoL; in contrast to asth-
ma, CF is a  rare, genetic disease and CF manage-
ment (use of antibiotics, dornase alfa inhalation, 
physiotherapy and lung transplantation) adds up 
to higher expenditures than the medical treatment 
of bronchial asthma [8–10]. Monitoring quality of 
life and incorporating patient reported outcomes 
(PRO) into daily treatment strategies could ensure 
optimal disease management and adequate health 
care utilization by the patient [11–13]. In routine 
clinical practice there is a  need for valid, reliable 
and easy-to-use methods to evaluate quality of life. 
A simple way is to use a generic quality of life in-
strument, such as the PedsQLTM [1, 4]. The other 
important issue is to what degree is it possible to re-
ly on the child’s self assessment and how adequately 
can caregivers assess their children’s quality of life. 
Our aim was to assess HRQoL with a general 
quality of life questionnaire, to evaluate the degree 
of agreement of child self-report assessment and 
parent proxy-report and to analyze the relation 
between PRO and clinical status or opinion of the 
healthcare professional indicated by spirometry.
Material and Methods
Participants and Settings
Patients were enrolled at 5 outpatient pedi-
atric units [Department of Pediatrics, Pulmono-
logical Institute (Torokbalint); CF Unit, Heim Pal 
Children’s  Hospital, (Budapest); 1st Department 
of Pediatrics, Semmelweis University, (Budapest); 
Department of Pediatrics, Kaposi Mor Teaching 
Hospital, (Mosdos); Department of Pediatrics, 
Velkey Laszlo Pediatric Health Center, Borsod-
Abauj-Zemplen County and University Teaching 
Hospital, (Miskolc)] in Hungary during the period 
September 2010 to October 2011.
Inclusion criteria included confirmed diagno-
sis of asthma or CF, age between 8–18 years, pres-
ence of one caregiver during the measurement. 
Children with acute respiratory infection, co-mor-
bidity and mental retardation or incapacity to 
complete the questionnaires were excluded from 
participation. Children and parents completed the 
questionnaires simultaneously and separately.
One hundred ninety children were asked to par-
ticipate in our study. Of these 8 (4.21%) had acute 
respiratory infection during the study, 4 (2.11%) pa-
tients suffered from other chronic illnesses (juvenile 
chronic arthritis, hydronephrosis, hypertonia, dis-
order of consciousness), 6 (3.16%) parents did not 
complete the HRQoL questionnaires. A total of 172 
(90.53%) children with a confirmed diagnosis of CF 
or asthma were included for the final analysis. 
Spirometry
Forced vital capacity (FVC), forced expira-
tory volume in 1  s  (FEV1) and forced expiratory 
flow at 25–75% of forced vital capacity (FEF25–75%) 
were measured, all expressed as the percentage of 
the best predicted value based on gender, age and 
height.
HRQoL
This was assessed with the Hungarian ver-
sion of the Pediatric Quality of Life InventoryTM 
v. 4.0  (PedsQLTM 4.0) Generic Core Scale. Ped-
sQLTM Generic Core Scale is a widely used gener-
ic HRQoL instrument for a range of children and 
teenagers from 2 to 18 years of age [1, 14–15].
The PedsQLTM 4.0  Generic Core Scale con-
sists of an overall HRQoL score, the 23-item total 
scale score; an 8-item physical health subscale and 
a  15-item psychosocial health subscale. The psy-
chosocial health subscale is composed of a 5-item 
emotional functioning subscale, a  5-item social 
functioning subscale and a 5-item school function-
ing subscale.
The PedsQLTM 4.0 Generic Core Scale is com-
prised of both a child self-report and parent proxy-
report format. We used the child self-report (8–12, 
13–18 years) and parent proxy-report (8–12, 13–18 
years) versions. The questions refer to the past 
month [16–18]. 
The minimal clinically meaningful difference 
is a  4.4  total score change for child self-report 
and a  4.5  total score change for parent proxy- 
-report [19].
Consent and Ethics Approval
Written informed consent was obtained from 
all parents and of patients over 14 years of age who 
agreed to participate in our study. The study has 
been approved by the Semmelweis University Re-
gional and Institutional Committee of Science and 
Research Ethics (118/2010).
Our survey was performed in accordance with 
the ethical standards laid down in the 1964 Decla-
ration of Helsinki.
Statistical Analyses 
Descriptive statistics (means, standard devia-
tions and frequencies) were used to characterize 
the demographic variables, spirometry and scale 
scores for PedsQLTM. Pearson’s  correlation coef-
ficient (r) was used to observe the strength of the 
relationships. Differences between the 2 patient 
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groups were tested using the Pearson chi-square 
test for categorical variables and the Mann-Whit-
ney U test for continuous variables.
The significance level considered was p  ≤  0.05. 
Correlation coefficients (r) are defined as weak, if 
r < 0.3, moderate if r = 0.3–0.7 and strong if r > 0.7 [20].
The agreement between child self- and parent 
proxy-report on the PedsQLTM 4.0  was assessed 
using intra-class correlation coefficients (ICC). 
ICC ≥ 0.80 is usually taken as evidence that a scale 
is highly reliable between the rates [21]. ICC can be 
interpreted as follows: ≤ 0.40 indicates poor agree-
ment; 0.41–0.6  indicates moderate agreement; 
0.61–0.8 indicates good agreement and ≥ 0.81 in-
dicates excellent agreement [22].
PedsQLTM scores were analyzed across two age 
groups (children 8–12 years and teenagers 13–18 
years) using ANOVA.
Statistical analyses were performed using Sta-
tistical Package for the Social Sciences for Win-
dows v. 15.0 (SPSS 15.0). 
Results
Sample Characteristics
One hundred seventy two children and their par-
ents joined our study. The mean age of the patients 
was 11.6 + 2.56 years (range: 8.0–18.0 years), 54.7 % 
were male. 78.9% of the parents were mothers, the 
parents’ mean age was 38.9 + 6.02 years (range: 26.0–
62.0 years). The response rate was over 97%.
The characteristics of the children and their 
parents are summarized in Table 1. Significant 
differences were found between the two disease 
groups in gender, FVC, FEV1 and FEF25–75% val-
ues. A  significantly higher proportion of patients 
(40.5% vs. 18.3%) were hospitalized with cystic 
fibrosis (p  ≤ 0.005). We observed more frequent 
passive smoking among asthmatic patients than in 
the CF patient group (29.2% vs. 10.3%, p < 0.05). 
Parents’ educational level was similar in the 2 pa-
tient groups (Table 1).
Table 1. Participant characteristics (n = 172)
Asthma
(n = 133)
Cystic fibrosis
(n = 39)
p-value
Patient
Age in years, mean + SDa  11.5 + 2.5 11.8 + 2.8 0.711
Gender, n (%) male  83 (62.4%) 11 (28.2%) 0.0012
FVCb(%), mean (range) 109.3 (78.0–162.0) 92.1 (33.0–136.0) 0.0011
FEV1c(%), predicted, mean (range) 100.7 (65.0–139.0) 80.6 (24.0–121.0) 0.0011
FEF25–75%d(%), mean (range)  85.8 (37.0–166.0) 64.6 (7.0–124.0) 0.0011
MMAS-8e score, mean (range)   6.4 (3.0–8.0)  6.0 (1.0–8.0) 0.691
Hospitalization
Yes, n (%)  24 (18.3) 15 (40.5) 0.0052
Parent
Mother n (%) 104 (78.8) 31 (79.5) 0.932
Education
Primary school n (%)
High school n (%)
College degree or beyond n (%)
 36 (27.5)
 62 (47.3)
 33 (25.2)
10 (25.6)
17 (43.6)
11 (28.2)
0.312
Chronic diseases
Yes, n (%)  30 (23.1)  6 (15.4) 0.302
Smoking
Yes, n (%)  38 (29.2)  4 (10.3) 0.022
a SD – standard deviation.
b FVC – forced vital capacity.
c FEV1 – forced expiratory volume in 1 s.
d FEF25–75% – forced expiratory flow at 25–75% of forced vital capacity.
e MMAS-8 – morisky medication adherence scale 8-Item.
1 Mann-Whitney U test.  
2 Pearson c2 test. 
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Comparison of PedsQLTM Scores 
of the Different Patient Groups
Table 2 presents mean PedsQLTM scores. We 
found significantly lower total PedsQLTM scores in 
all domains except physical and social functioning 
in CF children compared to asthma with the child 
self-report perspective and the measured difference 
was clinically significant. In the case of the parent 
proxy-report, we could not detect any significant 
differences between the two patient groups. 
Internal consistency coefficients for each domain 
were calculated using the Cronbach α. The reliabili-
ty coefficients ranged from r = 0.88 to 0.93 (Table 2).
Comparing the HRQoL of asthmatic and CF 
patients in age groups with child self-report, as 
shown in Table 3; in our young (8–12 years) pa-
tients we observed a significantly lower score only 
on the school functioning subscale among CF pa-
tients (p < 0.01). In teenagers (13–18 years), signif-
icant differences were detected between PedsQLTM 
psychosocial health (p < 0.05), emotional function-
ing (p < 0.05) and total scale  did not (p < 0.05). The 
results presented in Table 3 did not show any sig-
nifcant differences for the parent proxy-report in 
both age groups across disease groups. 
Parent-Child Agreement
Intra-class correlation coefficients (ICC) be-
tween the child self-report and parent proxy-report 
are presented in Table 4. A significant agreement 
between dyads (proxy and child self-report) was 
observed across all scales (p < 0.001). The level of 
agreement between child self- and proxy-report 
was poor in the case of asthma (ICCasthma = 0.29–
0.37) and was moderate in CF patient (ICCCF = 
0.39–0.59). 
Correlation Between PedsQLTM 
Child Self-Report  
and Spirometry
To evaluate the clinical utility of the PedsQLTM, 
correlations were calculated between the scores of 
the PedsQLTM and spirometry parameters (FVC, 
FEV1 and FEF 25–75%), correlation rates are sum-
marized in Table 5. In the case of CF, we found 
mainly moderate correlations between the HRQoL 
data and spirometry. In the case of asthma, in-
terestingly, we found negative weak correlations 
in our younger patients between FEF 25–75% 
and the psychosocial health subscale (r  = –0.26, 
p  < 0.05), the emotional functioning subscale 
(r = –0.23, p < 0.05), the school functioning (r = –0.32, 
p < 0.01), the total scale score (r = –0.23, p < 0.05); 
between the school functioning subscale and FEV1 
(r  = –0.26, p  < 0.05). In the case of the parent 
proxy-report, significant correlations were found 
only between the CF patients’ physical score and 
FVC (r  = 0.58), FEV1 (r  = 0.54) and FEF25–75% 
Table 2. Comparison of mean PedsQL™ Generic Core Scale scores of children with asthma to those of children with cystic fibrosis
aPedsQL™ subscales Asthma Cystic fibrosis p-value*
number mean + SDb Cronbach α number mean + SD Cronbach α
Child self-report
Physical health 133  79.14 + 14.95 0.88 39 72.92+17.42  0.93 0.061
Psychosocial health
Emotional function
Social functioning
School functioning
133
133
133
133
80.58 + 13.58
78.59 + 17.59 
84.96 + 18.40
78.30 + 15.33
0.88
0.89
0.89
0.88
39
39
39
39
75.34 + 13.96
70.38 + 17.30
85.00 + 16.58
70.51 + 14.63
 0.92
 0.92
 0.93
 0.93
0.028
0.005
0.778
0.002
Total score 133 80.22 + 13.04 0.88 39 74.70 + 13.89  0.92 0.023
Parent proxy-report
Physical health 129 71.12 + 16.48 0.89 39 70.03 + 22.53  0.92 0.859
Psychosocial health
Emotional function
Social functioning
School functioning
129
129
129
129
72.22 + 14.80
67.26 + 19.61
80.11 + 19.75
68.89 + 18.75
0.88
0.89
0.89
0.89
38
38
39
39
73.89 + 15.24
69.87 + 21.54
81.83 + 16.19
69.20 + 16.87
 0.92
 0.93
 0.93
 0.92
0.728
0.461
0.844
0.989
Total score 129 71.74 + 13.90 0.88 39 73.47 + 15.79  0.92 0.580
a PedsQL™ – Pediatric Quality of Life Inventory ™4.0 Generic Core Scales.
b SD – standard deviation.
* Mann-Whitney U test.
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Table 4. Intra-class correlation coefficients between PedsQLTM 4.0 Generic Core Scales for parent proxy-report and child 
self-report in different patient groups
Patient groups Physical 
health
Psychosocial 
health
Emotional 
functioning
Social  
functioning
School  
functioning
Total score
Asthma
(n = 133)
0.35 0.34 0.29 0.31 0.33 0.37
Cystic fibrosis
(n = 39)
0.59 0.47 0.39 0.39 0.42 0.47
All correlations are significant at the p < 0.001 level.
Table 5. Pearson correlation coefficients between parameters of spirometry and PedsQL™ 4.0 Generic Core Scales in differ-
ent diagnostic groups
aPedsQL™ subscales Asthma Cystic fibrosis
FVCb FEV1c FEF25–75%d FVC FEV1 FEF25–75%
Child self-report (8–12 years)
Physical health  0.01 –0.01 –0.08  0.46*  0.49**  0.43*
Psychosocial health
Emotional functioning
Social functioning
School functioning
–0.59
–0.05
 0.03
–0.14
–0.18
–0.18
–0.03
–0.26*
–0.26*
–0.23*
–0.10
–0.32**
 0.34
 0.17
 0.37
 0.29
 0.31
 0.15
 0.31
 0.30
 0.40*
 0.26
 0.30
 0.43*
Total score –0.05 –0.15 –0.23*  0.35  0.31  0.36
Parent proxy-report (8–12 years)
Physical health –0.03  0.14  0.15  0.58**  0.54**  0.43*
Psychosocial health
Emotional functioning
Social functioning
School functioning
–0.04
–0.12
 0.08
–0.05
 0.06
–0.04
 0.13
 0.08
 0.034
–0.03
 0.07
 0.06
 0.30
 0.38
 0.19
 0.11
 0.30
 0.37
 0.22
 0.12
 0.29
 0.34
 0.21
 0.17
Total score –0.02  0.14  0.12  0.41*  0.41*  0.37
Child self-report (13–18 years)
Physical health  0.18 0.04 –0.12  0.29  0.58*  0.70*
Psychosocial health
Emotional functioning
Social functioning
School functioning
 0.06
 0.09
 0.08
–0.04
–0.13
–0.09
–0.09
–0.16
–0.22
–0.18
–0.15
–0.22
 0.14
–0.14
 0.28
 0.20
 0.36
 0.12
 0.43
 0.40
 0.34
 0.29
 0.28
 0.33
Total score  0.11 –0.08 –0.20  0.17  0.43  0.46
Parent proxy-report (13–18 years)
Physical health  0.11 –0.03 –0.13  0.43  0.43  0.20
Psychosocial health
Emotional functioning
Social functioning
School functioning
–0.05
 0.02
 0.05
–0.20
–0.10
–0.11
 0.04
–0.17
–0.10
–0.20
 0.02
–0.06
 0.24
 0.14
 0.26
 0.14
 0.04
–0.08
 0.06
 0.16
–0.29
–0.30
–0.34
 0.04
Total score –0.01 –0.09 –0.12  0.27  0.17 –0.08
  * p < 0.05 (2-tailed).
** p < 0.01 (2-tailed).
a PedsQLTM-Pediatric Quality of Life InventoryTM 4.0 Generic Core Scales.
b FVC –Forced Vital Capacity.
c FEV1 – Forced Expiratory Volume in 1 s.
d FEF25–75% – Forced Expiratory Flow at 25–75% of forced vital capacity.
Quality of Life of Children 493
(r = 0.43) and between the total score and spirom-
etry parameters.
In our teenagers (13–18 years), we found sig-
nificant relationships only in CF, which was mod-
erate between the physical health subscale and 
FEV1 (r = 0.58, p < 0.05) and FEF25–75% (r = 0.70, 
p < 0.05) by the child self-report.
Hungarian healthy controls’ general Ped-
sQLTM data was previously assessed by Berkes et al. 
The data is summarized in Table 3 [23].
Discussion
HRQoL deterioration compared to the gen-
eral population of the two chronic diseases was 
evaluated, both with child self-assessment and 
parent proxy-report. In pediatric conditions it is 
widely discussed whether to ask the patient him- 
or herself or rather the caregiver, in order to be 
able to evaluate disease progress and HRQoL 
[24–26]. 
Our results demonstrate that both asth-
ma and CF have a  substantial impact on the 
child’s  HRQoL. As expected, patients with CF 
perceive their HRQoL as poorer on psychosocial 
health, and expressively on the emotional func-
tioning and school functioning subscales and on 
the total scale score, than children with asthma as-
sessed with the child self-report. 
In the 8–12 year-old age group, HRQoL is dete-
riorated mainly on the school functioning subscale 
in patients with CF. In the older age group, teenag-
ers (13–18 years) suffering from CF, life with sig-
nificantly poorer HRQoL regarding all psychoso-
cial subscales (except school functioning and social 
functioning) and the total scale of the PedsQLTM 
than teenagers with asthma measured by child self-
report. This could be explained by the phenome-
non that younger children do not completely un-
derstand their illness yet, but teenagers do realize 
the essence of their disease. Teenagers with CF fa-
vor their healthy friends, so they would like to live 
a sterling life but they need to recognize that they 
have limitations on account of their physical con-
dition, their lung function, and they also have to 
care about their daily obligatory inhalation thera-
py. None of these impact on asthmatic teenagers; 
it is well documented in the literature that children 
with CF usually spend more time on their treat-
ment [27–28]. Children suffering from asthma can 
live roughly normal lives if their asthma is well 
controlled. They could only face some limitations 
on physical functioning, and with physical educa-
tion. Their HRQoL may deteriorate if they have an 
exacerbation but not permanently on a day to day 
basis, in contrast to CF, which is a progressive dis-
ease with a  continually decreasing lung function 
and physical condition.
Measuring HRQoL with parent proxy-re-
port in both age groups (8–12 and 13–18 years), 
we could not find any statistically or clinically sig-
nificant differences. In a previous publication, the 
age of the child was identified as a  factor affect-
ing the level of parent-child agreement, healthy 
children of an older age have the ambition to de-
clare autonomy and so cause higher disagreement 
between parents and children [24, 29]. Neverthe-
less, parents, who are outsiders, have just some 
impressions of how is it to live with a chronic re-
spiratory disease in childhood. From an external 
viewpoint, an exacerbation in asthma could be 
frightening and parents might consequently un-
derestimate their child’s  HRQoL. Caregivers of 
CF patients, who know better the progress of their 
child’s illness, have a better understanding of their 
child’s  limitations and they are used to this con-
dition; hence they are more likely to overestimate 
their child’s  HRQoL. This might be the reason 
why parents of asthmatic children perceive their 
child’s  HRQoL similarly to the way CF patients’ 
parents do. Previous publications have highlighted 
the importance of regular communication direct-
ly to the children and adolescents about their ill-
ness and the fact that caregivers cannot completely 
reflect the self-estimation of their child’s  HRQoL 
[2, 24–26]. On the other hand, if parents are self-
confident regarding the management of their chil-
dren’s disease, besides leading to improved QoL of 
the child, at the same time it could result in more 
rational health care utilization as well.
Concerning the agreement of the patient re-
ported outcomes and the clinical outcomes, our re-
sults suggest a generally weak correlation between 
spirometry and HRQoL in children with asthma.
The weak, negative correlations observed be-
tween spirometry and PedsQLTM scores in asth-
matic children are interesting since clinicians as-
sess their patients’ health status mainly according to 
spirometry in routine care. Our survey highlighted 
that decreased lung function could bring on poor-
er HRQoL of CF patients; a non-linear relationship 
was found between asthma patient’s  HRQoL and 
spirometry. Clinicians could not estimate which 
domain of HRQoL is deteriorated in patients with 
asthma on the basis of the spirometry.
In contrast to asthma, in CF we measured mod-
erate correlations between physical health and spi-
rometry parameters in both age groups from the 
child self-report. Therefore in the course of asth-
ma care it is difficult to conclude how the patient 
is feeling only based on spirometry. As our results 
show, a child having good lung function could live 
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with a poor HRQoL or vice versa. Hence clinicians 
should assess both lung function and quality of life, 
estimating their patients’ objective and subjective 
parameters together.
It is known that children with asthma might 
live with poor HRQoL even if they have good 
lung function. Since they are stigmatized or be-
cause they are afraid of exacerbations, using reliev-
er medications in public could be a  sticky affair. 
Our discrepant associations were similar to the 
observations of Juniper et al. in pediatric asthma 
[3]. Another study identified the impact of asth-
ma on daily life as a stressor, which could increase 
emotional problems for children with asthma [30]. 
CF patients experience severe limitations day by 
day. If they have a better period without exacerba-
tions, their lung function improves, having a direct 
positive impact on their HRQoL. 
We found significant differences between 
healthy children’s quality of life and the HRQoL of 
our patients. An interesting discrepancy was found 
between the HRQoL scores of children with asth-
ma and the PedsQLTM scores of healthy children. 
In the 8–12-year old age group, asthmatics per-
ceived their HRQoL better than healthy children 
in the emotional functioning domain assessed 
with the child self-report in contrast to the parent 
proxy-report. In the 13–18-year old age group, ac-
cording to child self-report, almost every aspect of 
the psychosocial domain was assessed with higher 
scores by children with asthma than healthy chil-
dren. In CF we could not find this kind of differ-
ence. These aspects reflect that measuring HRQoL 
could be quite complex and different in childhood 
than in adulthood. Another explanation could be 
that children with asthma were excluded from 
our study if they had an exacerbation in the pe-
riod of measuring. Therefore patients whose asth-
ma was well-controlled took part in our survey and 
their HRQoL was quite better than healthy chil-
dren’s because they could compare their life with 
exacerbation or without. Healthy children could 
not imagine how much worse their life might be if 
they had to live with a chronic disease.
It is also important to determine who is ade-
quate to perceive the child’s HRQoL in the differ-
ent chronic diseases with different characteristics. 
As our results suggest, not only the chronological 
age and the domain type of the questionnaire have 
an effect on the agreement between children’s and 
parents’ reports, but it also depends on the type of 
the disease. 
Our study had some limitations. This was not 
a  nationwide study, only a  multicenter one. Our 
results from this cross-sectional study were not 
sufficient to highlight the importance of longitudi-
nal, follow up measures. 
In conclusion, PedsQLTM is a  useful instru-
ment, it provides a better understanding of the as-
pects of the HRQoL of both asthma and CF and so 
it may help in treatment optimization collectively 
with the clinical parameters. In CF caregivers and 
the children assessed, the child’s HRQoL was very 
similar, independently from the age, so clinicians 
could ask either the child or the caregivers, where-
as in asthma it is not enough to assess HRQoL only 
from the child’s perspective, since children could 
not perceive their HRQoL realistically in contrast 
to the caregivers’. Irrespective of the age group, 
in the course of holistic asthma care, not only re-
spect of the clinical status is essential but also the 
HRQoL by parent proxy-report.
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